| Intrinsic Valuation of: MEDANTA | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 18 | Market Cap | ₹309B | |||||
| 2021 | - | - (-) | P/E Ratio | 64 | Total Asset | ₹48B | |||||
| 2022 | ₹368M | - (-) | Net Income | ₹5B | Total Debt | ₹3B | |||||
| 2023 | ₹4B | 1010.5% (797.1%) | EBITDA | ₹9B | Total Liab | ₹14B | |||||
| 2024 | ₹3B | -18.4% (-33.1%) | Opr Margin | 0.19 | Debt/Equity | 0.08 | |||||
| 2025 | ₹-242M | -107.2% (-106.4%) | PreTax Margin | 16.74 | BV/Share | 126 | |||||
| 5Y Average FCF | ₹2B | 295.0% (219.2%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | ₹2B | MBG Intrinsic Value | ₹161 | ||||||||
| 2027 | ₹3B | ||||||||||
| 2028 | ₹4B | ||||||||||
| 2029 | ₹5B | ||||||||||
| 2030 | ₹6B | ||||||||||
| 2031 | ₹7B | ||||||||||
| Terminal Value | ₹150B | Net Worth/Share | ₹126 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹117B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹2B | ₹435 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹3B | WACC | 7.3% | 378 | 408 | 445 | 490 | 546 | |||
| Equity Value | ₹117B | 7.4% | 374 | 404 | 440 | 484 | 539 | ||||
| Shares Outstanding | 268,696,992 | 7.4% | 371 | 400 | 435 | 478 | 532 | ||||
| 7.9% | 339 | 363 | 391 | 425 | 467 | ||||||
| DCF Intrinsic Value | ₹435 | 8.4% | 311 | 332 | 355 | 383 | 416 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||